• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pT1期传统型(透明细胞)肾细胞癌:与癌症特异性生存相关的病理特征

Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival.

作者信息

Cheville J C, Blute M L, Zincke H, Lohse C M, Weaver A L

机构信息

Departments of Pathology and Laboratory Medicine, Urology and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

J Urol. 2001 Aug;166(2):453-6. doi: 10.1016/s0022-5347(05)65962-9.

DOI:10.1016/s0022-5347(05)65962-9
PMID:11458046
Abstract

PURPOSE

The features predictive of aggressive behavior in stage pT1 conventional (clear cell) renal cell carcinoma are not completely known. We evaluated pathological features in a large series of stage pT1 conventional renal cell carcinoma cases and examined the association of these features with cancer specific survival.

MATERIALS AND METHODS

Patients with solitary stage pT1 conventional renal cell carcinoma who underwent radical nephrectomy between 1970 and 1997 were eligible for study. For each of the 46 patients who died of renal cell carcinoma we selected a stratified random sample of at least 3 year matched controls who were still alive or dead of other causes. The study included 277 patients. We evaluated patient age at nephrectomy, sex, tumor size, Fuhrman grade, necrosis and sarcomatoid component. Univariate and multivariate Cox proportional hazards models were fit to assess the features associated with cancer specific survival.

RESULTS

Multivariate modeling revealed that tumor size, Fuhrman grade and necrosis were jointly significantly associated with cancer specific survival. Of the 4.5, 5 and 6 cm. tumor size cutoffs examined on univariate analysis a cutoff of 5 cm. or greater was most predictive of cancer specific survival.

CONCLUSIONS

In stage pT1 conventional renal cell carcinoma Fuhrman grade, tumor necrosis and tumor size together were jointly significantly associated with cancer specific survival. Specifically of the tumor size cutoffs analyzed the 5 cm. cutoff was most predictive of cancer specific survival.

摘要

目的

pT1期传统型(透明细胞)肾细胞癌侵袭性行为的预测特征尚不完全清楚。我们评估了大量pT1期传统型肾细胞癌病例的病理特征,并研究了这些特征与癌症特异性生存的相关性。

材料与方法

1970年至1997年间接受根治性肾切除术的孤立性pT1期传统型肾细胞癌患者符合研究条件。对于46例死于肾细胞癌的患者,我们为每位患者选择了至少3年匹配的对照组,这些对照组仍存活或死于其他原因。该研究包括277例患者。我们评估了肾切除时的患者年龄、性别、肿瘤大小、Fuhrman分级、坏死和肉瘤样成分。采用单因素和多因素Cox比例风险模型评估与癌症特异性生存相关的特征。

结果

多因素建模显示,肿瘤大小、Fuhrman分级和坏死与癌症特异性生存显著相关。在单因素分析中检查的4.5、5和6厘米肿瘤大小临界值中,5厘米或更大的临界值对癌症特异性生存的预测性最强。

结论

在pT1期传统型肾细胞癌中,Fuhrman分级、肿瘤坏死和肿瘤大小共同与癌症特异性生存显著相关。具体而言,在所分析的肿瘤大小临界值中,5厘米临界值对癌症特异性生存的预测性最强。

相似文献

1
Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival.pT1期传统型(透明细胞)肾细胞癌:与癌症特异性生存相关的病理特征
J Urol. 2001 Aug;166(2):453-6. doi: 10.1016/s0022-5347(05)65962-9.
2
pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.pT1期透明细胞肾细胞癌:MIB-1增殖活性与病理特征及癌症特异性生存之间的关联研究
Cancer. 2002 Apr 15;94(8):2180-4. doi: 10.1002/cncr.10433.
3
Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.根治性肾切除术后病理分期为T1期肾细胞癌的预后特征。
Urology. 2002 Apr;59(4):532-7. doi: 10.1016/s0090-4295(01)01589-8.
4
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.在多变量环境中,pNx/pN0分组对透明细胞肾细胞癌患者预后建模的影响。
J Urol. 2002 Jul;168(1):56-60.
5
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.基于肿瘤分期、大小、分级和坏死情况的接受根治性肾切除术的透明细胞肾细胞癌患者的预后预测模型:SSIGN评分
J Urol. 2002 Dec;168(6):2395-400. doi: 10.1016/S0022-5347(05)64153-5.
6
[Pathological prognostic indicators in renal cell carcinoma].[肾细胞癌的病理预后指标]
Actas Urol Esp. 2010 Jan;34(1):71-7.
7
Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.肾周脂肪浸润和肿瘤大小在肾细胞癌中的预后意义
J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.
8
The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma.三维肿瘤体积对pT1期透明细胞肾细胞癌患者癌症特异性生存的影响。
World J Urol. 2016 Jan;34(1):83-8. doi: 10.1007/s00345-015-1592-6. Epub 2015 May 17.
9
Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.对于接受肾部分切除术治疗 pT1 透明细胞肾细胞癌的患者,肾脏大小与癌症特异性生存的关系。
Urology. 2012 Jul;80(1):147-50. doi: 10.1016/j.urology.2012.04.013.
10
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?在 CORONA 项目的一项综合多中心研究中评估肾细胞癌患者 pT1-pT3a 局限性肿瘤中肾周脂肪侵犯和肿瘤大小的预后意义。我们能否改善 pT3a 期肿瘤患者的预后判别?
Eur Urol. 2015 May;67(5):943-51. doi: 10.1016/j.eururo.2014.11.055. Epub 2015 Feb 13.

引用本文的文献

1
Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database.转移性透明细胞肾细胞癌患者癌症特异性生存预测列线图的开发与验证:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2022 Sep 28;12:949058. doi: 10.3389/fonc.2022.949058. eCollection 2022.
2
Development and internal validation of nomograms for the prediction of postoperative survival of patients with grade 4 renal cell carcinoma (RCC).用于预测4级肾细胞癌(RCC)患者术后生存率的列线图的开发与内部验证
Transl Androl Urol. 2020 Dec;9(6):2629-2639. doi: 10.21037/tau-19-687.
3
A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
一种双 DNA 甲基化标志物,可改善肾透明细胞癌的预后预测。
Yonsei Med J. 2019 Nov;60(11):1013-1020. doi: 10.3349/ymj.2019.60.11.1013.
4
Renal cell carcinoma.肾细胞癌。
Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9.
5
Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size.囊性肾细胞癌无论肿瘤大小,预后都很好。
Urol Oncol. 2015 Dec;33(12):505.e9-13. doi: 10.1016/j.urolonc.2015.07.017. Epub 2015 Aug 28.
6
Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.缺氧诱导的鲽鱼降钙素-1过表达与早期透明细胞肾细胞癌的转移有关。
J Transl Med. 2015 Feb 12;13:56. doi: 10.1186/s12967-015-0421-4.
7
Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma.肾细胞癌的全病灶定量CT评估:透明细胞肾细胞癌与乳头状肾细胞癌的鉴别
Springerplus. 2015 Feb 10;4:66. doi: 10.1186/s40064-015-0823-z. eCollection 2015.
8
The impact of tumour size on the probability of synchronous metastasis and survival in renal cell carcinoma patients: a population-based study.肿瘤大小对肾细胞癌患者同步转移概率和生存的影响:一项基于人群的研究。
BMC Urol. 2014 Aug 31;14:72. doi: 10.1186/1471-2490-14-72.
9
High-level expression of Notch1 increased the risk of metastasis in T1 stage clear cell renal cell carcinoma. Notch1 的高表达增加了 T1 期透明细胞肾细胞癌转移的风险。
PLoS One. 2012;7(4):e35022. doi: 10.1371/journal.pone.0035022. Epub 2012 Apr 10.
10
Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.T1N0M0期肾细胞癌:亚洲患者的预后
Chin J Cancer. 2011 Nov;30(11):772-8. doi: 10.5732/cjc.011.10085.